Effect of cardiac dysfunction on treatment outcomes in women receiving trastuzumab for HER2-overexpressing metastatic breast cancer.
Clinical breast cancer.
Times cited: 21
Cardiac dysfunction in the trastuzumab clinical trials experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 859
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
The New England journal of medicine.
Times cited: 7022